Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dario Health Corp (NQ: DRIO )

4.120 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dario Health Corp

< Previous 1 2 Next >
DarioHealth's Return On Capital Employed Insights
 
Via Benzinga
Earnings Preview: DarioHealth
 
Via Benzinga
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?
DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform. 
Via News Direct
CVS Deal To Buy Oak Street At $39 Per Share Brings Arbitrage Opportunity, Says StoryTrading's Rabizadeh
Healthcare giant CVS Health Corp. (NYSE: CVS) announced on Wednesday a definitive agreement to buy primary healthcare provider Oak Street Health Inc. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
10 Stocks Under $10 for 2023
In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10. 
Via InvestorPlace
DarioHealth: Q2 Earnings Insights
  DarioHealth (NASDAQ:DRIO) reported its Q2 earnings results on Monday, August 15, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: DarioHealth Q1 Earnings
DarioHealth (NASDAQ:DRIO) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation
DarioHealth Corp. (NASDAQ: DRIO) Prominently Positioned for Digital Therapeutics Consolidation 
Via News Direct
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
Recap: DarioHealth Q4 Earnings
DarioHealth (NASDAQ:DRIO) reported its Q4 earnings results on Tuesday, March 22, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
In a couple of years, Dario Heath could easily be a $100M+ company running 60%+ gross margins, be profitable and cash generating. 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million. 
Via Benzinga
US Stocks Open Higher Ahead Of Fed Decision, Dow Jumps 175 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 175 points on Wednesday. The Federal Reserve will announce its policy decision at 2:00 p.m. ET. The country’s central bank is... 
Via Benzinga
Looking Into DarioHealth's Return On Capital Employed
Benzinga Pro data, DarioHealth (NASDAQ:DRIO) reported Q2 sales of $6.18 million. Earnings fell to a loss of $18.03 million, resulting in a 13.27% decrease from last quarter. 
Via Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
DarioHealth Corp. (NASDAQ: DRIO) recently announced 
Via Benzinga
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and... 
Via Benzinga
DarioHealth Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q1, DarioHealth's (NASDAQ:DRIO) reported sales totaled $8.06 million. Despite a 26.27% increase in earnings, the company posted a loss of $15.92 million. 
Via Benzinga
Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan Rumored To Be Aetna (AET)
Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan Rumored to be Aetna (AET) - Fundamentals: Company positioned to avoid dilutive financing after... 
Via Benzinga
Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know
Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
Upgrades 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY)
Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space... 
Via Benzinga
Earnings Outlook For DarioHealth
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that DarioHealth... 
Via Benzinga
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a... 
Via Benzinga
DarioHealth's Return On Capital Employed Overview
According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million. 
Via Benzinga
Earnings Scheduled For March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.